| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. | J Natl Cancer Inst | 2002 | 2.25 |
| 2 | HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer. | Int J Cancer | 2008 | 1.44 |
| 3 | Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. | Clin Cancer Res | 2008 | 0.87 |
| 4 | Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients. | Thromb Haemost | 2003 | 0.87 |
| 5 | Mineral oil paraffins in human body fat and milk. | Food Chem Toxicol | 2007 | 0.80 |
| 6 | Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix. | Cancer Lett | 2008 | 0.75 |